Avid Bioservices (CDMO) Insider Trading & Ownership $12.37 +0.01 (+0.08%) (As of 10:52 AM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Avid Bioservices (NASDAQ:CDMO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.05%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$423,264.89 Get CDMO Insider Trade Alerts Want to know when executives and insiders are buying or selling Avid Bioservices stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CDMO Insider Buying and Selling by Quarter Ad Porter & CompanyForbes rich list released… #1 to be assassinated?Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.To get the full details on the fake “energy crisis” of America, watch this now Avid Bioservices Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/14/2024Matthew R KwietniakInsiderSell119$10.15$1,207.85 10/10/2024Nicholas Stewart GreenCEOSell17,173$10.05$172,588.65 10/10/2024Richard A RichieriInsiderSell2,031$10.05$20,411.55 7/15/2024Richard A RichieriInsiderSell530$8.36$4,430.80 7/12/2024Matthew R KwietniakInsiderSell119$8.05$957.95 7/10/2024Nicholas Stewart GreenCEOSell7,657$7.54$57,733.78 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 7/10/2024Richard A RichieriInsiderSell910$7.54$6,861.40 4/30/2024Daniel R HartCFOSell2,826$7.40$20,912.40 4/30/2024Mark R ZiebellGeneral CounselSell1,643$7.40$12,158.20 4/30/2024Nicholas Stewart GreenCEOSell11,762$7.40$87,038.80 4/30/2024Richard A RichieriInsiderSell1,005$7.40$7,437.00 1/12/2024Matthew R KwietniakInsiderSell274$6.77$1,854.98 1/10/2024Daniel R HartCFOSell2,408$6.17$14,857.36 1/10/2024Mark R ZiebellGeneral CounselSell1,346$6.17$8,304.82 1/10/2024Richard A RichieriInsiderSell1,055$6.17$6,509.35 (Data available from 1/1/2013 forward) CDMO Insider Trading Activity - Frequently Asked Questions Who is on Avid Bioservices's Insider Roster? The list of insiders at Avid Bioservices includes Daniel R Hart, Gregory Sargen, Joseph Carleone, Mark R Ziebell, Matthew R Kwietniak, Nicholas Stewart Green, Richard A Richieri, and Richard B Hancock. Learn more on insiders at CDMO. What percentage of Avid Bioservices stock is owned by insiders? 3.05% of Avid Bioservices stock is owned by insiders. Learn more on CDMO's insider holdings. Which Avid Bioservices insiders have been buying company stock? The following insiders have purchased CDMO shares in the last 24 months: Joseph Carleone ($190,600.00), and Richard B Hancock ($134,780.00). How much insider buying is happening at Avid Bioservices? Insiders have purchased a total of 43,000 CDMO shares in the last 24 months for a total of $325,380.00 bought. Which Avid Bioservices insiders have been selling company stock? The following insiders have sold CDMO shares in the last 24 months: Daniel R Hart ($325,178.25), Gregory Sargen ($141,902.64), Mark R Ziebell ($549,536.91), Matthew R Kwietniak ($9,793.95), Nicholas Stewart Green ($1,607,316.74), Richard A Richieri ($95,924.20), and Richard B Hancock ($506,800.00). How much insider selling is happening at Avid Bioservices? Insiders have sold a total of 233,454 Avid Bioservices shares in the last 24 months for a total of $3,236,452.69 sold. Avid Bioservices Key ExecutivesMr. Nicholas Stewart Green B.Sc. (Age 59)MBA, President, CEO & Director Compensation: $699.01k2 recent tradesMr. Daniel R. Hart (Age 51)Chief Financial Officer Compensation: $497.16kMr. Richard A. Richieri (Age 59)Chief Operations Officer Compensation: $411.91k3 recent tradesMr. Mark R. Ziebell J.D. (Age 60)VP, General Counsel & Corporate Secretary Compensation: $477.16kMr. Matthew R. Kwietniak (Age 55)Chief Commercial Officer Compensation: $409.43k2 recent tradesMs. Oksana LukashVice President of People More Insider Trading Tools from MarketBeat Related Companies Xenon Pharmaceuticals Insider Transactions Amicus Therapeutics Insider Transactions Merus Insider Transactions ACADIA Pharmaceuticals Insider Transactions Zai Lab Insider Transactions Gemini Therapeutics Insider Transactions Vera Therapeutics Insider Transactions Bausch Health Companies Insider Transactions Arrowhead Pharmaceuticals Insider Transactions Dyne Therapeutics Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:CDMO) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avid Bioservices, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avid Bioservices With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
